Free Trial

Catalent (CTLT) Stock Forecast & Price Target

$57.91
-0.08 (-0.14%)
(As of 04:31 PM ET)

Catalent - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 11 Wall Street analysts who have issued ratings for Catalent in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 7 have given a hold rating, and 3 have given a buy rating for CTLT.

Consensus Price Target

$55.65
-3.90% Downside
High Forecast$63.50
Average Forecast$55.65
Low Forecast$42.00

According to the 11 analysts' twelve-month price targets for Catalent, the average price target is $55.65. The highest price target for CTLT is $63.50, while the lowest price target for CTLT is $42.00. The average price target represents a forecasted downside of -3.90% from the current price of $57.91.

TypeCurrent Forecast
7/20/23 to 7/19/24
1 Month Ago
6/20/23 to 6/19/24
3 Months Ago
4/21/23 to 4/20/24
1 Year Ago
7/20/22 to 7/20/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$55.65$54.05$52.46$56.25
Forecasted Upside-3.90% Downside8.17% Upside8.40% Upside19.78% Upside
Get Catalent Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CTLT and its competitors with MarketBeat's FREE daily newsletter.

CTLT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTLT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Catalent Stock vs. The Competition

TypeCatalentMedical CompaniesS&P 500
Consensus Rating Score
2.18
2.72
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-4.04% Downside1,352.65% Upside9.15% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/11/2024Royal Bank of Canada
4 of 5 stars
 Reiterated RatingSector Perform ➝ Sector Perform$63.50 ➝ $63.50+10.15%
6/28/2024Barclays
2 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$47.00 ➝ $63.00+11.98%
4/4/2024Stephens
4 of 5 stars
 Reiterated RatingEqual Weight ➝ Equal Weight$63.50+12.09%
2/6/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Neutral$58.00 ➝ $63.50+6.15%
11/16/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$50.00 ➝ $42.00+6.17%
11/16/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$45.00 ➝ $53.00+33.97%
11/14/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform
9/5/2023Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$62.00+23.51%
8/31/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderperform ➝ Underperform$39.00 ➝ $46.00-8.20%
8/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$52.00 ➝ $55.00+9.26%
8/15/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$37.00 ➝ $45.00-0.97%
6/14/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$45.00 ➝ $44.00+0.34%
5/21/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$90.00 ➝ $45.00+21.07%
11/2/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$125.00 ➝ $85.00+71.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:58 PM ET.

CTLT Forecast - Frequently Asked Questions

What is Catalent's forecast for 2024?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Catalent is $55.65, with a high forecast of $63.50 and a low forecast of $42.00.

Should I buy or sell Catalent stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Catalent in the last year. There is currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CTLT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CTLT, but not buy additional shares or sell existing shares.

Does Catalent's stock price have much upside?

According to analysts, Catalent's stock has a predicted upside of 10.07% based on their 12-month stock forecasts.

What analysts cover Catalent?

Catalent has been rated by research analysts at Barclays, and Royal Bank of Canada in the past 90 days.

Do Wall Street analysts like Catalent more than its competitors?

Analysts like Catalent less than other "medical" companies. The consensus rating for Catalent is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CTLT compares to other companies.


This page (NYSE:CTLT) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners